Surge in Ozempic Overdoses Sparks Concern and High Volume of Poison Control Calls

Poison control centers in the US have seen a 1,500% surge in calls related to semaglutide, sold as Ozempic for diabetes and Wegovy for weight loss, with the majority of calls involving dosing issues. Some users turned to compounded versions of semaglutide due to a supply shortage, which can deviate from the patented form and potentially lead to overdoses. While it is difficult to determine whether the calls are related to patented or compounded semaglutide, some state poison center directors believe compounded versions are driving a significant number of the calls.